2025 SPS Minneapolis | Hodgkin Lymphoma Front Line Efficacy & Toxicity Considerations

2025 SPS Minneapolis | Hodgkin Lymphoma Front Line Efficacy & Toxicity Considerations

Overview

NA

Target Audience

Pharmacists

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Adrienne Nedved, PharmD, MPA, BCOP

Date of Release

September 13th, 2025